Holen Sie sich die Stockscreener-App
2.29
8.40%
-0.21
Vorhandelsmarkt:
2.20
-0.09
-3.93%
Schlusskurs vom Vortag:
$2.50
Offen:
$2.54
24-Stunden-Volumen:
254.44K
Relative Volume:
0.18
Marktkapitalisierung:
$23.84M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-45.57M
KGV:
-0.3635
EPS:
-6.3
Netto-Cashflow:
$-38.56M
1W Leistung:
+11.17%
1M Leistung:
+7.51%
6M Leistung:
+94.07%
1J Leistung:
-9.13%
1-Tages-Spanne:
$2.27
$2.59
1-Wochen-Bereich:
$2.055
$2.60
52-Wochen-Spanne:
$1.00
$6.60
Sab Biotherapeutics Inc Stock (SABS) Company Profile
Firmenname
Sab Biotherapeutics Inc
Sektor
Branche
Telefon
305-845-2813
Adresse
777 W 41ST ST, MIAMI BEACH
Vergleichen Sie SABS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SABS
Sab Biotherapeutics Inc
|
2.29 | 26.03M | 0 | -45.57M | -38.56M | -6.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Sab Biotherapeutics Inc Stock (SABS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-17 | Eingeleitet | Leerink Partners | Outperform |
| 2025-05-14 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-10-09 | Eingeleitet | Craig Hallum | Buy |
| 2024-08-28 | Eingeleitet | Oppenheimer | Outperform |
| 2021-11-05 | Eingeleitet | Chardan Capital Markets | Buy |
Sab Biotherapeutics Inc Aktie (SABS) Neueste Nachrichten
Why retail investors pile into SAB Biotherapeutics Inc. stock2025 Historical Comparison & AI Driven Stock Movement Reports - newser.com
Is SAB Biotherapeutics Inc. stock bottoming outJuly 2025 Snapshot & Free High Accuracy Swing Entry Alerts - newser.com
SAB Biotherapeutics Inc. Equity Warrant stock outlook for YEARWeekly Trade Report & AI Powered Buy/Sell Recommendations - newser.com
Is SAB Biotherapeutics Inc a good long term investmentInsider Trading Activity & Big Profit Low Investment - earlytimes.in
Should you wait for a breakout in SAB Biotherapeutics Inc.Quarterly Earnings Report & Risk Controlled Daily Plans - newser.com
Using Ichimoku Cloud for SAB Biotherapeutics Inc. Equity Warrant technicalsWeekly Trade Recap & Precise Buy Zone Identification - newser.com
How to track smart money flows in SAB Biotherapeutics Inc. Equity WarrantJuly 2025 EndofMonth & Weekly Top Gainers Alerts - newser.com
Is SAB Biotherapeutics Inc. stock reversal real or fake2025 Market Outlook & Risk Managed Investment Strategies - newser.com
COMMODORE CAPITAL LP Acquires Significant Stake in SAB Biotherapeutics Inc - GuruFocus
RA CAPITAL MANAGEMENT, L.P. Acquires Significant Stake in SAB Biotherapeutics Inc - GuruFocus
Will SAB Biotherapeutics Inc. Equity Warrant stock recover after recent dropWeekly Trade Summary & Verified Short-Term Trading Plans - newser.com
Will SAB Biotherapeutics Inc. Equity Warrant bounce back from current supportJuly 2025 Review & Daily Technical Forecast Reports - newser.com
Can SAB Biotherapeutics Inc. stock sustain institutional interest2025 Volume Leaders & Growth Focused Entry Reports - newser.com
How to interpret RSI for SAB Biotherapeutics Inc. stockTrade Volume Report & Real-Time Sentiment Analysis - newser.com
Advanced analytics toolkit walkthrough for SAB Biotherapeutics Inc.Market Growth Summary & Real-Time Chart Breakout Alerts - newser.com
Is SAB Biotherapeutics Inc. stock entering bullish territoryWeekly Risk Report & Weekly Top Gainers Trade List - newser.com
Will SAB Biotherapeutics Inc. Equity Warrant stock benefit from upcoming earnings reportsCEO Change & High Return Trade Opportunity Guides - newser.com
Published on: 2025-10-09 02:46:01 - newser.com
What drives SAB Biotherapeutics Inc stock priceIPO Market Watch & High Return Trading Ideas - earlytimes.in
Can technical indicators confirm SAB Biotherapeutics Inc.’s reversalEarnings Recap Summary & Risk Managed Investment Entry Signals - newser.com
Institutional scanner results for SAB Biotherapeutics Inc. Equity Warrant2025 Historical Comparison & Reliable Intraday Trade Plans - newser.com
Strategies to average down on SAB Biotherapeutics Inc. Equity WarrantWeekly Loss Report & Community Verified Swing Trade Signals - newser.com
Will SAB Biotherapeutics Inc. see short term momentumDollar Strength & Fast Entry High Yield Stock Tips - newser.com
Full technical analysis of SAB Biotherapeutics Inc. stockJuly 2025 Decliners & Target Return Focused Picks - newser.com
Will a bounce in SAB Biotherapeutics Inc. Equity Warrant offer an exit2025 Pullback Review & Expert Approved Momentum Ideas - newser.com
Using data filters to optimize entry into SAB Biotherapeutics Inc.Entry Point & Advanced Technical Signal Analysis - newser.com
Published on: 2025-10-05 04:55:13 - newser.com
Is SAB Biotherapeutics Inc. Equity Warrant stock a buy in volatile markets2025 Key Lessons & Low Risk High Win Rate Picks - newser.com
Will breakout in SAB Biotherapeutics Inc. Equity Warrant lead to full recovery - newser.com
Published on: 2025-10-05 03:02:18 - newser.com
SAB story? T1D competitors may cry on further ATG data - BioWorld MedTech
Visual trend scoring systems applied to SAB Biotherapeutics Inc. Equity WarrantQuarterly Trade Report & Precise Buy Zone Tips - newser.com
Published on: 2025-10-01 03:59:17 - newser.com
SAB Biotherapeutics Board Members Resign in Agreement - TipRanks
SAB Biotherapeutics reduces board size following resignations of two directors - Investing.com Canada
Finanzdaten der Sab Biotherapeutics Inc-Aktie (SABS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Sab Biotherapeutics Inc-Aktie (SABS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Sessa Capital (Master), L.P. | Director |
Sep 29 '25 |
Option Exercise |
1.75 |
1,740,000 |
3,045,000 |
2,198,457 |
5.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):